Instalab
logoInstalab

Triglycerides

Blood Test
A blood-fat signal that often moves early with insulin resistance and marks pancreatitis risk when it gets very high.
4.9 (2,684 reviews)
Tested by Quest, Access Medical, Boston Heart or ZRT
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers · 8-hour fast required
Get results
Explained with clear next steps, no medical jargon

Should you take a Triglycerides test?

This test is most useful if any of these apply to you.

Healthy but Want to Stay Ahead
Your triglycerides can show early strain in fat and sugar handling before glucose looks clearly abnormal.
Told Your Blood Sugar Is Borderline
A rising triglyceride, especially with low HDL, often points to insulin resistance behind prediabetes.
Worried About Family Patterns
If very high triglycerides run in your family, close tracking can help catch pancreatitis-level rises earlier.
Carrying Weight Around Your Middle
Belly weight often comes with liver fat, and triglycerides are a cheap early clue that it may be happening.

About Triglycerides

Triglycerides are the lipid number most likely to move with how you eat, drink, and carry weight. When they climb, it often means your body is taking in more fuel than it can burn or store well, and the excess is showing up in your blood as fat.

Your result is a serum triglyceride. Some large studies measure plasma triglycerides instead. For triglycerides, serum and plasma are both blood-draw measurements of the same fat molecules, so lipid research usually treats them together.

That makes triglycerides an early clue for insulin trouble, sometimes before fasting glucose looks clearly abnormal. At the high end they become a separate problem, because enough triglyceride in the blood can inflame your pancreas.

What the Number Reflects

Triglycerides are fat molecules carried through your blood inside particles that your liver and gut build to move fat around. After a meal, your gut packs dietary fat into large particles. Between meals, your liver exports its own fat as VLDL. VLDL is short for very low-density lipoprotein.

Your result is the running balance between how much fat these particles bring in and how fast your body clears them. It is a readout of whole-body energy handling, not one organ.

When insulin stops working well, the liver makes more of these fat-carrying particles and clears them more slowly. High triglycerides are a classic sign of insulin resistance. As they rise, the rest of the lipid picture often shifts with them: more leftover remnant particles and smaller, denser LDL.

Heart and Artery Risk

High triglycerides travel with heart disease, but the signal is muddier than most people assume. In a study of about 1.5 million people, the most extreme triglyceride group was not linked to heart attack, while moderate elevations were. The same extreme group was strongly tied to pancreatitis, diabetes, and death. So the triglyceride number alone is not a clean artery-risk test.

The artery-damaging part appears to be the cholesterol carried inside triglyceride-rich remnant particles. Remnant cholesterol is related to triglycerides but is not the same measurement. In a Danish genetic study, a 39 mg/dL genetically higher remnant-cholesterol level was tied to about 2.8 times the risk of heart disease caused by narrowed arteries.

In type 2 diabetes, higher triglycerides track with more cardiovascular disease, but the link weakens once other lipids are accounted for. Triglycerides ride alongside risk more than they clearly cause it. ApoB is apolipoprotein B. It counts the harmful particles themselves. In about 294,000 adults, apoB stayed predictive after accounting for triglycerides, while triglycerides did not stay predictive once apoB was included.

So don't read a normal triglyceride as an all-clear for your heart, and don't read a high one as a verdict. Pair it with apoB to see the harmful-particle burden.

Acute Pancreatitis

This is where triglycerides carry their sharpest signal. Enough triglyceride in the blood can set off sudden, severe inflammation of the pancreas. In the 1.5 million-person study, triglycerides in the most extreme group carried about 14 times the risk of acute pancreatitis and about 25 times the risk of chronic pancreatitis.

Even well below extreme levels, a higher triglyceride at hospital admission predicts a worse course. A meta-analysis found roughly 70% higher odds of severe acute pancreatitis, with more organ failure and more pancreatic tissue death. The number needs to be checked early, because it can fall within a day or two of an attack and hide the cause.

Insulin Resistance and Type 2 Diabetes

Very high triglycerides were tied to more than five times the rate of new diabetes diagnoses in the same large study. Some diagnoses happened soon after the triglyceride test, so part of the signal may be diabetes found during the same workup. The biology still fits: rising triglycerides are one of the earliest signs that insulin is losing its grip on fuel handling.

Pairing triglycerides with HDL cholesterol sharpens the picture. Across about 14,000 people in three cohorts, a high triglyceride-to-HDL ratio flagged metabolic syndrome, insulin resistance, and more severe atherosclerosis. It can turn abnormal before fasting glucose does.

Fatty Liver Disease

Fat building up inside the liver is closely tied to triglyceride handling. In a cross-sectional study of U.S. adults, the triglyceride-to-HDL ratio predicted metabolic dysfunction-associated steatotic liver disease better than triglycerides or HDL alone. MASLD means fat buildup in the liver tied to metabolic dysfunction. A high triglyceride is one of the cheapest early hints that the liver may be storing fat.

Kidney Function

Higher triglycerides also track with worse kidney outcomes. In about 2,200 people with chronic kidney disease, triglycerides were independently linked to kidney decline, and a large study of diabetic veterans found the same, though the strength varied with baseline kidney function and protein in the urine.

Why Low Isn't Always Good News

In people with heart failure, low triglycerides were tied to a higher risk of death and readmission, while high triglycerides tracked with artery disease. That looks backward until you see what may be going on. In someone already seriously ill, a low triglyceride can reflect poor nutrition or physical wasting, not good metabolic health. The same number means different things in a healthy 40-year-old and a frail patient with advanced heart failure. Read your value against the rest of your health, not as a simple good-number, bad-number scale.

Why One Reading Is Not Enough

Triglycerides swing more than most lipids from day to day, driven mostly by what and when you last ate. A single value can mislead you in either direction. The trend over time tells you far more than any one draw.

When Results Can Be Misleading

  • Recent food: a fatty or heavy meal raises triglycerides for hours. This is the biggest short-term distortion, and it fades on its own.
  • Alcohol in the last day or two: even a single evening of drinking can inflate the number before any lasting change has happened.
  • Lab method: some labs do not subtract background glycerol from the measurement, which overestimates triglycerides. In more than 1,500 samples, this shifted people into higher risk categories they did not belong in.
  • Acute illness: infection or another sudden stress can move the number temporarily and does not reflect your usual level.
  • Medication changes: estrogen therapy, steroids, retinoids, some HIV medicines, beta blockers, and thiazide diuretics can raise triglycerides in some people. That is a real drug effect, not proof that insulin resistance suddenly got worse.

What an Unexpected Result Should Make You Do

A high triglyceride is a prompt to look wider, not to panic. Check fasting glucose and HbA1c, then look at the triglyceride-to-HDL ratio for insulin resistance. Add apoB, because a normal LDL can be falsely reassuring when triglycerides are high, since the usual calculated LDL becomes unreliable at very high triglyceride levels.

The combinations matter more than any one value. High triglycerides alongside high apoB and high glucose is a metabolic syndrome pattern that warrants aggressive action. High triglycerides with normal apoB and normal glucose is lower priority unless the triglyceride itself is very high. A very high triglyceride is a pancreatitis concern that deserves prompt medical attention, and extreme or inherited elevations are worth a conversation with a lipid specialist or endocrinologist.

What Moves This Biomarker

Evidence-backed interventions that affect your Triglycerides level

Decrease
Lose excess weight and cut refined carbohydrates, added sugar, and alcohol
This is the standard first step before any drug, and triglycerides respond to it faster than most other lipids. Cutting refined carbohydrates and added sugar, losing excess weight, drinking less, and improving blood sugar all bring the number down, often within weeks. For very high triglycerides, a very-low-fat diet and no alcohol are used to lower pancreatitis risk.
DietStrong Evidence
Decrease
Take prescription icosapent ethyl, purified EPA omega-3, 4 grams a day
Icosapent ethyl lowers triglycerides and, in statin-treated high-risk adults with elevated triglycerides, cut major cardiovascular events by about a quarter. EPA is one type of omega-3 fat. Mixed EPA/DHA products can lower triglycerides too, but large outcome trials have not shown the same heart benefit.
MedicationStrong Evidence
Decrease
Take pemafibrate, a fibrate-like triglyceride-lowering drug
Pemafibrate genuinely lowers triglycerides. In a large randomized trial, it cut triglycerides by 26.2% at four months but did not reduce heart attacks or strokes over about three years, and it slightly increased kidney problems and blood clots. So it lowers the number without proven heart benefit in that population, and it is not a substitute for lowering apoB.
MedicationStrong Evidence
Decrease
Take an apoC-III inhibitor, olezarsen, for familial chylomicronemia syndrome
In familial chylomicronemia syndrome, a rare inherited disorder of extreme triglycerides, monthly olezarsen lowered triglycerides much more than placebo and the trial recorded far fewer pancreatitis attacks over one year. ApoC-III is a protein that slows triglyceride clearance. This is for severe genetic disease, not ordinary insulin-resistant triglyceride elevation.
MedicationStrong Evidence
Increase
Drink alcohol regularly
Regular alcohol raises triglycerides, which is why cutting back is one of the most reliable ways to lower them. Heavy drinking can push triglycerides high enough to threaten the pancreas.
LifestyleModerate Evidence
Decrease
Take a statin when cardiovascular risk is high
Statins usually lower triglycerides modestly, especially when the starting value is high. Their main value is lowering apoB and LDL cholesterol and reducing heart events. They are the drug backbone when triglycerides are part of cardiovascular risk, not when the immediate concern is pancreatitis-level triglycerides.
MedicationModest Evidence
Decrease
Check and correct low vitamin D in type 2 diabetes
In people with type 2 diabetes, vitamin D supplements lowered triglycerides by about 9 mg/dL on average in pooled trials. That is a small effect and does not replace diet, weight loss, alcohol reduction, or glucose control.
SupplementModest Evidence
Decrease
Take zinc supplements
Zinc supplements lowered triglycerides by about 11 mg/dL across pooled controlled trials, though results varied a lot between studies. Healthy participants did not show a clear triglyceride drop. It is a minor lever, not a primary treatment.
SupplementModest Evidence

Frequently Asked Questions

Panels containing Triglycerides

Triglycerides is included in these pre-built panels.

References

23 studies
  1. Patel R, Pasea L, Soran H, Downie P, Jones R, Hingorani a, Neely D, Denaxas S, Hemingway HCardiovascular Diabetology2022
  2. Kiss L, Fűr G, Mátrai P, Hegyi P, Ivány E, Cazacu I, Szabó I, Habon T, Alizadeh H, Gyöngyi Z, Vigh É, Erőss B, Erős a, Ottóffy M, Czakó L, Rakonczay ZScientific Reports2018
  3. Hidalgo N, Pando E, Alberti P, Vidal L, Mata R, Fernandez N, Gómez-jurado MJ, Dopazo C, Blanco L, Tasayco S, Molero X, Balsells J, Charco RWorld Journal of Surgery2022